Monday, February 6, 2012

http://crdd.osdd.net/oscat/register.html


Open Source Drug Discovery (OSDD) is organizing 2nd International conference on open source for computer-aided Translational medicine, at Institute of Microbial Technology, Chandigarh, India. This conference will be useful for scientific community working in the field of drug discovery particularly on Mycobacterium tuberculosis. This conference will be organized in February 2012 (22nd to 25th Feb.). Following are major objectives of this conference
  • Promoting open source in therapeutics.
  • Role of computer in translational research.
  • Integration of in silico & wet-lab experiments.
  • Bring wide range of experts (in silico to clinical) on single platform.
  • Discuss current status of therapeutics in tuberculosis.
CSIR-Institute of Microbial Technology, Chandigarh
Importance of Translational Medicine: Despite tremendous progress in the field of medicine, research are unable to discover/develop effective medicine against various dread diseases. Due to lack of effective medicine, we have several millions of immature deaths every year world-wide. Thus their is a need to promote translational research (transforming basic research into medicines), in order to improve quality of life. Translational medicine needs wide range of expertise from basic science to clinical (bench to bedside). In this conference attempt will be made to bring wide range of experts on single platform, who are directly or indirectly working in the field of translational research in therapeutics.

Open Source for Drug Discovery (OSDD)OSDD Forum is an initiative with a vision to provide affordable healthcare to the developing world. The OSDD concept aims to synergize the power of genomics, computational technologies and facilitate the participation of young and brilliant talent from universities and industry. It seeks to provide a global platform where the best brains can collaborate and collectively endeavor to solve the complex problems associated with discovering novel therapies for neglected diseases particularly Tuberculosis.